Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Evotec — Just – Evotec Biologics

Tracked across 2 events · 13 articles · First seen Jun 30, 2026 · Last active Sep 09, 2026

Sentiment
45
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Tech
Impact: Evotec — Just – Evotec Biologics, a wholly-owned subsidiary of Evotec SE, is the direct developer and provider of the J.TRAIN platform, which represents a strategic shift towards a capital-lighter and technology-focused business model for the company.
Jun 30, 2026 · 7 articles
4 20
Business
Evotec SE announced the initiation of a Phase 1 clinical trial for JST-018, a cocktail of investigational monoclonal antibodies targeting orthopoxviruses, developed by its subsidiary Evotec — Just – Evotec Biologics under the U.S. Department…
Impact: As the developer and manufacturer, Evotec — Just – Evotec Biologics achieved a key milestone, validating its continuous manufacturing platform and strengthening its portfolio of government contracts.
Sep 09, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Evotec — Just – Evotec Biologics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.